4.7 Article

T cell responses against microsatellite instability-induced frameshift peptides and influence of regulatory T cells in colorectal cancer

Related references

Note: Only part of the references are listed.
Article Immunology

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

Jason D. Fontenot et al.

JOURNAL OF IMMUNOLOGY (2017)

Article Gastroenterology & Hepatology

Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers

Yvette Schwitalle et al.

GASTROENTEROLOGY (2008)

Article Oncology

Prediction of the immunogenic potential of frameshift-mutated antigens in microsatellite instable cancer

Frank M. Speetjens et al.

INTERNATIONAL JOURNAL OF CANCER (2008)

Article Oncology

Beta2-microglobulin mutations in microsatellite unstable colorectal tumors

Matthias Kloor et al.

INTERNATIONAL JOURNAL OF CANCER (2007)

Review Oncology

CD4 regulatory T cells in human cancer pathogenesis

Keith L. Knutson et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)

Review Oncology

Carcinoembryonic antigen-based vaccines

J Marshall

SEMINARS IN ONCOLOGY (2003)

Article Immunology

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

JD Fontenot et al.

NATURE IMMUNOLOGY (2003)

Review Medicine, General & Internal

Genomic medicine - Hereditary colorectal cancer

HT Lynch et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Article Multidisciplinary Sciences

Control of regulatory T cell development by the transcription factor Foxp3

S Hori et al.

SCIENCE (2003)

Review Immunology

Cancer immunoediting: from immunosurveillance to tumor escape

GP Dunn et al.

NATURE IMMUNOLOGY (2002)

Article Multidisciplinary Sciences

Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer

I Saeterdal et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Article Oncology

Frameshift peptide-derived T-cell epitopes: a source of novel tumor-specific antigens

M Linnebacher et al.

INTERNATIONAL JOURNAL OF CANCER (2001)